- Home
- BBGI vs VYNE Comparison
BBGI vs VYNE Comparison
Compare BBGI & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- VYNE
- Stock Information
- Founded
- BBGI 1961
- VYNE 2003
- Country
- BBGI United States
- VYNE United States
- Employees
- BBGI N/A
- VYNE N/A
- Industry
- BBGI Broadcasting
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- VYNE Health Care
- Exchange
- BBGI Nasdaq
- VYNE Nasdaq
- Market Cap
- BBGI 8.3M
- VYNE 7.9M
- IPO Year
- BBGI 2000
- VYNE 2018
- Fundamental
- Price
- BBGI $5.55
- VYNE $0.30
- Analyst Decision
- BBGI
- VYNE Buy
- Analyst Count
- BBGI 0
- VYNE 2
- Target Price
- BBGI N/A
- VYNE $8.00
- AVG Volume (30 Days)
- BBGI 2.9K
- VYNE 1.7M
- Earning Date
- BBGI 11-04-2025
- VYNE 11-06-2025
- Dividend Yield
- BBGI N/A
- VYNE N/A
- EPS Growth
- BBGI N/A
- VYNE N/A
- EPS
- BBGI N/A
- VYNE N/A
- Revenue
- BBGI $227,387,784.00
- VYNE $476,000.00
- Revenue This Year
- BBGI $5.02
- VYNE N/A
- Revenue Next Year
- BBGI N/A
- VYNE N/A
- P/E Ratio
- BBGI N/A
- VYNE N/A
- Revenue Growth
- BBGI N/A
- VYNE N/A
- 52 Week Low
- BBGI $3.67
- VYNE $0.28
- 52 Week High
- BBGI $14.95
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- BBGI 73.07
- VYNE 32.11
- Support Level
- BBGI $5.27
- VYNE $0.30
- Resistance Level
- BBGI $4.80
- VYNE $0.33
- Average True Range (ATR)
- BBGI 0.11
- VYNE 0.02
- MACD
- BBGI 0.08
- VYNE 0.02
- Stochastic Oscillator
- BBGI 99.95
- VYNE 39.83
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.